Menopause: Key Factor in Endometrial Cancer

Microbiome signature which is in part promoted by post menopause was associated with endometrial cancer. Endometrial cancer is the most common gynecological malignancy in the U.S.

A microbiome signature linked to endometrial cancer, which is in part promoted by post menopause has been discovered by Mayo Clinic researchers and published in Scientific Reports. The goal of the study was to understand how endometrial cancer risk factors alter the reproductive tract microbiome and endometrial cancer risk.

Endometrial cancer is the most common gynecological malignancy in the U.S. and the fourth most common cancer among women. In addition, endometrial cancer incidence rates are on the rise in the western world, suggesting that alterations in environmental factors such as diet, lifestyle, and the vaginal microbiome may be important drivers in its cause.

Endometrial Cancer
Cancer of the Endometrium, or the inner lining of the uterus (womb) is called endometrial cancer.

‘Scientists have investigated the role of the microbiome in endometrial cancer and potentially how to prevent the actions of harmful bacteria to the host.’

"If the microbiome does play a role in endometrial cancer, beyond being a marker for it, this could have important implications for endometrial cancer prevention," says Marina Walther-Antonio, Ph.D., lead author of the Mayo Clinic study.

According to Dr. Walther-Antonio the established role of the vaginal microbiome as a key factor in vaginal and obstetric health, as well as vaginal microbiome differences found between different ethnicities adds to the importance of exploring the microbiome in endometrial cancer.

The research team previously found microbiome differences between patients with and without endometrial cancer in a uterine microbiome study published in 2017 that led to the development of a vaginal swab screening methodology used for endometrial cancer."

Quiz on Menopause
Menopause is inevitable in a woman’s life and it would be apt to be well prepared for it. Learn more about menopause and the best ways of managing it by going through this quiz.

"The new study gave us the knowledge and application needed to further develop this screening tool for endometrial cancer," says Dr. Walther-Antonio.

Overall, the team verified the main known risk factors for endometrial cancer (postmenopausal status and obesity) and identified high vaginal pH as an additional factor associated with patients with endometrial cancer.

Link Between Gene Mutation Combo and Endometrial Cancer
Mutations of the ARID1A and PIK3CA genes are frequently found together in the development of endometrial cancer, as well as in endometriosis-associated ovarian cancer.

"We have determined that all of these factors impact the reproductive tract microbiome, further identified post menopause as a key factor, and are looking ahead to discuss potential translational applications of this knowledge, which may bring new approaches to address current health disparities in endometrial cancer," says Dr. Walther-Antonio.

This work was supported by the Mayo Clinic Center for Individualized Medicine Microbiome Program and the John W. Anderson Foundation. This project was supported by CTSA Grant Number KL2 TR002379 from the National Center for Advancing Translational Science (NCATS). This work was also supported, in part, by a career enhancement award from NIH grant P50 CA136393.

Molecular Analysis Could Improve the Early Detection and Prevention of Endometrial Cancer, Says Study
Scientists said genomic analyzes in cervical were found to improve the detection of cancer of the uterine cavity.

The authors declare the following competing interests: The Mayo Foundation for Medical Education and Research (inventors Andrea Mariani, Nicholas Chia and Marina Walther-Antonio) applied for a patent application "Methods and Materials for Treating Endometrial Cancer", US 2017/0260571 A1 (published September 14th, 2017). The use of Porphyrmonas somerae and accompanying microbiota as biomarkers for the detection of endometrial cancer is covered in the patent. Marina Walther-Antonio is a member of the scientific advisory board of LUCA Biologics, Inc. on research related to urinary tract infections, preterm birth, and reproductive medicine. These activities do not overlap with the research presented here.

Source-Eurekalert